Ggynex Pharma Private Limited

Ggynex Pharma Private Limited - health and wellness services in Ambala, Haryana, India. FY 2026 financials & compliance.
CIN U46497HR2022PTC104654 Incorporated 24 June 2022 ROC Delhi HQ Ambala, Haryana, India
Active Private Limited Company health and wellness services MSME · Micro
Revenue · FY 2023
₹4.11 Lakh
Latest filing
Net loss · FY 2023
₹10.64 Lakh
Net margin -259.2%
EBITDA · FY 2023
-₹10.06 Lakh
EBITDA margin -244.9%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Company age
4 yrs
Est. 2022
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Ggynex Pharma Private Limited

Data last updated:

Ggynex Pharma Private Limited is a private limited company based in Ambala, Haryana, India. It operates in the beauty salons and wellness spas segment of the health and wellness sector. It was incorporated on 24 June 2022.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U46497HR2022PTC104654. Its GSTIN is 06AAJCG8652L1Z2 (Haryana).

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Manisha Sansarwal and Shivom Sharma.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at H No 98 Jaggi Colony Ambala City, Haryana, India – 134007.

As per the financials filed for FY 2023, the company reported a revenue of ₹4.11 Lakh. For the same year it recorded a net loss of ₹10.64 Lakh (net margin -259.2%) and EBITDA of -₹10.06 Lakh (EBITDA margin -244.9%).

Ggynex Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-13-0010107).

Company details

CIN U46497HR2022PTC104654
Registration Number 104654
Incorporation Date 24 June 2022
ROC Delhi
Listing Status Unlisted
Company Status Active
MSME Classification Micro
Udyam Registration UDYAM-HR-13-0010107

CIN history

Ggynex Pharma has one previous CIN (Corporate Identification Number): U74999HR2022PTC104654. The current CIN is U46497HR2022PTC104654, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U46497HR2022PTC104654Current
U74999HR2022PTC104654Previous

Recognitions & Rankings of Ggynex Pharma

MSME (Udyam registered) Ministry of MSME
Category
Micro (2022-23)
Udyam number
UDYAM-HR-13-0010107

Contact details

Ggynex Pharma Private Limited's registered office is in Ambala, Haryana.

  • Registered Address
    H No 98 Jaggi Colony Ambala City, Haryana, India – 134007
  • Industry
    Health and Wellness Services, Beauty Salons & Wellness Spas
Comprehensive company report
Ggynex Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Ggynex Pharma is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GWholesale and retail trade; repair of motor vehicles and motorcycles46Wholesale trade, except of motor vehicles and motorcycles

To see the full business activity and turnover split of Ggynex Pharma Private Limited, buy the company report.

Financials of Ggynex Pharma Private Limited

FY 2024 filings available

Ggynex Pharma Private Limited reported revenue of ₹4.11 Lakh for FY 2023.

Revenue · FY 2023
₹4.11 Lakh
Net loss · FY 2023
₹10.64 Lakh margin -259.2%
EBITDA · FY 2023
-₹10.06 Lakh margin -244.9%

Financial Statement Summary

MetricsFY 2022-23
Profit and Loss Statement
Revenue from Operations₹4.11 Lakh
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹10.06 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹10.64 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2022-23
Profitability
EBITDA Margin-244.9%
Net Profit Margin-259.2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Ggynex Pharma Private Limited, buy the company report.

Board of directors of Ggynex Pharma Private Limited

Ggynex Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Manisha SansarwalDirector24 Jun 20224 Years 4 MonthsCurrent
Shivom SharmaDirector07 Oct 20224 Years 1 MonthsCurrent

MSME payment delays

No delayed payments to MSME suppliers are on our record for Ggynex Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Ggynex Pharma has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
06AAJCG8652L1Z2HaryanaActive09 Aug 2022

To see the full GST registrations and return filing status of Ggynex Pharma Private Limited, buy the company report.

Recent activity

Ggynex Pharma Private Limited has 4 board changes on record since 2022: 2 appointments and 2 cessations. The latest: Gurnam Singh ceased to be Additional Director on 09 Oct 2022.

AGM
Ggynex Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Ggynex Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Ceased
Gurnam Singh ceased to be Additional Director.
Appointed
Shivom Sharma was appointed as Director.
Ceased
Shivom Sharma ceased to be Director.
Appointed
Manisha Sansarwal was appointed as Director.
Incorporation
24 Jun 2022
Ggynex Pharma Private Limited was registered on 24 Jun 2022 with Roc Delhi & aged 4 years 5 months as per MCA records.

Frequently asked questions

Ggynex Pharma is an active private limited company based in Ambala, Haryana, India. The company works in beauty salons and wellness spas, within the health and wellness services industry. It was incorporated on 24 June 2022 (4+ years old) and is registered under CIN U46497HR2022PTC104654.

Ggynex Pharma has 2 current directors:

The latest financial statements of Ggynex Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2023 are in the company report.

The GSTIN of Ggynex Pharma is 06AAJCG8652L1Z2, registered in Haryana.

The CIN (Corporate Identification Number) of Ggynex Pharma is U46497HR2022PTC104654. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Ggynex Pharma was incorporated on 24 June 2022, making it 4+ years old. It is registered with the Registrar of Companies, Delhi.

Gurnam Singh ceased to be Additional Director on 09 Oct 2022. Shivom Sharma was appointed as Director on 07 Oct 2022. Shivom Sharma ceased to be Director on 08 Aug 2022. Ggynex Pharma has 4 board changes on record in total.

Yes, Ggynex Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-HR-13-0010107).

The registered office of Ggynex Pharma is at H No 98 Jaggi Colony Ambala City, Haryana, India – 134007.

Ggynex Pharma operates in the health and wellness services industry, in the beauty salons and wellness spas segment.